FIELD: medicine; dermatology.
SUBSTANCE: histamine tests are run. Histamine is dropped on patient's forearm at intervals between tests, and skin under each test is scarified. Thereafter tests, without reference test, are coated with analysed dermatological agent. In 15-20 minutes size of formed papula and hyperaemia are recorded. For treatment purpose this product is selected provides highest inhibition of histamine reaction.
EFFECT: reduced time of estimation of dermatological product efficiency individually for each patient; higher efficiency of treatment and lowered risk of concurrent reactions and complications development.
2 ex, 6 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING IMMUNE DISEASES OF SKIN | 2006 |
|
RU2322990C2 |
| REMEDY FOR TREATING PRIMARY AND SECONDARY INFECTION SKIN DISEASES | 2006 |
|
RU2321409C1 |
| AGENT FOR TREATMENT OF SKIN IMMUNE DISEASE | 2006 |
|
RU2322987C2 |
| PHARMACEUTICAL AGENT FOR TREATMENT OF SKIN DISEASES WITH PRIMARY AND SECONDARY INFECTION | 2006 |
|
RU2323729C1 |
| REMEDY FOR TREATMENT OF MALIGNANT AND BENIGN NEOPLASMS OF DIFFERENT LOCALISATION | 2008 |
|
RU2391995C1 |
| METHOD OF ENHANCEMENT OF TREATMENT WITH GLUCOCORTICOID OINTMENT | 2000 |
|
RU2170092C1 |
| REMEDY FOR DISMENORREA TREATMENT | 2008 |
|
RU2391994C1 |
| REMEDY FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2008 |
|
RU2391996C1 |
| METHOD AND SET FOR TREATMENT OF INFLAMMATORY AND ALLERGIC DISEASES | 2004 |
|
RU2255744C1 |
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC AND INFLAMMATORY SKIN DISEASES | 2009 |
|
RU2440108C2 |
